Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Criteria for Causality: Bradford Hill Criteria - II

Criteria for Causality: Bradford Hill Criteria - II

The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:

Criteria for Causality: Bradford Hill Criteria - I

Criteria for Causality: Bradford Hill Criteria - I

The Bradford Hill criteria are a group of principles that provide a framework to determine a causal relationship between a specific factor and a disease. There are nine criteria that are pivotal in assessing causality in epidemiological studies. Here's a closer look at Strength, Consistency, Specificity, and Temporality criteria with definitions and examples:

Yield Criteria for Ductile Materials under Plane Stress

Yield Criteria for Ductile Materials under Plane Stress

In designing structural elements and machine parts using ductile materials, it is crucial to ensure that these components withstand applied stresses without yielding. Yielding is initially determined through a tensile test, which evaluates the material's response to uniaxial stress. However, tensile stress is insufficient when components face biaxial or plane stress conditions This condition requires advanced criteria to predict failure.
The Maximum Shearing Stress Criterion, also known as...

Criteria for Aromaticity and the Hückel 4n + 2 Rule

Criteria for Aromaticity and the Hückel 4n + 2 Rule

Like benzene, cyclobutadiene and cyclooctatetraene are cyclic compounds with alternate single and double bonds. However, their chemical behavior differs from benzene, as they are unstable and not aromatic. So, what are the structural characteristics of unsaturated compounds categorized as aromatic?
For the first time, Eric Hückel, a German chemical physicist, derived a set of structural features for a compound to be classified as aromatic. This is now known as Hückel’s rule or the 4n +...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Neurosurgeons Are Essential in the Interdisciplinary Care of Patients With Brain Metastasis.

Neurosurgery·2026

Same author

Cerebrovascular reactivity in migraine: a breath-hold BOLD fMRI study.

The journal of headache and pain·2026

Same author

Validation of Paw Skin Hyperspectral Imaging for Assessing Neuropathic Pain Severity in a Chronic Constriction Injury Model.

International journal of molecular sciences·2026

Same author

Editorial for "Infant Brain Age Estimation With T1w/T2w Ratio MRI: A Myelination-Aware Deep Learning Approach".

Journal of magnetic resonance imaging : JMRI·2026

Same author

Beyond the naked eye: a systematic review on the current state of radiomics approaches to the vestibular schwannoma.

Journal of neuro-oncology·2026

Same author

Correction: Caloric Restriction Attenuated Nerve Damages Mediated Through SIRT-1-a Study Using Nerve Crush Injury Model in Rats.

Molecular neurobiology·2026

Search research articles

Related Experiment Video

Updated: Jan 22, 2026

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Published on: August 29, 2018

ACR Appropriateness Criteria® Brain Tumors.

, Jana Ivanidze¹, Robert Y Shih²

¹Weill Cornell Medical College, New York, New York.

Journal of the American College of Radiology : JACR

|May 23, 2025

Summary

This summary is machine-generated.

This document provides evidence-based imaging recommendations for brain tumor management, guiding physicians on appropriate neuroimaging use for various clinical scenarios. It ensures optimal diagnostic accuracy and treatment planning for brain tumor patients.

Keywords:

AUC Appropriateness Criteria MRI PET appropriate use criteria brain metastases glioma meningioma

More Related Videos

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies

Published on: November 7, 2015

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on: May 31, 2020

Related Experiment Videos

Last Updated: Jan 22, 2026

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Published on: August 29, 2018

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies

Published on: November 7, 2015

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on: May 31, 2020

Area of Science:

Neuroimaging
Oncology
Radiology

Background:

Brain tumors are complex, requiring precise neuroimaging for diagnosis and management.
Advanced imaging tools necessitate clear guidelines for their appropriate application by physicians.

Purpose of the Study:

To establish evidence-based imaging recommendations for neuro-oncologic clinical scenarios.
To guide the appropriate use of conventional and advanced imaging modalities in brain tumor management.

Main Methods:

Utilizes the American College of Radiology Appropriateness Criteria framework.
Involves systematic analysis of peer-reviewed medical literature.
Employs the RAND/UCLA Appropriateness Method for procedure evaluation.
Incorporates expert opinion when literature is limited or equivocal.

Main Results:

Provides imaging recommendations for diverse neuro-oncologic scenarios.
Covers screening, pretreatment evaluation, posttreatment surveillance, and progression workup.
Addresses genetic risk, systemic malignancy, and intra-/extraaxial tumors.

Conclusions:

These guidelines enhance the appropriate use of neuroimaging in brain tumor care.
They support informed clinical decision-making for physicians treating brain tumors.
The recommendations aim to optimize patient outcomes through accurate diagnostics.